1. Home
  2. FMBH vs CTMX Comparison

FMBH vs CTMX Comparison

Compare FMBH & CTMX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Mid Bancshares Inc.

FMBH

First Mid Bancshares Inc.

HOLD

Current Price

$41.19

Market Cap

951.4M

Sector

Finance

ML Signal

HOLD

Logo CytomX Therapeutics Inc.

CTMX

CytomX Therapeutics Inc.

HOLD

Current Price

$4.73

Market Cap

977.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FMBH
CTMX
Founded
1865
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
951.4M
977.1M
IPO Year
1995
2015

Fundamental Metrics

Financial Performance
Metric
FMBH
CTMX
Price
$41.19
$4.73
Analyst Decision
Hold
Strong Buy
Analyst Count
5
10
Target Price
$43.40
$12.10
AVG Volume (30 Days)
113.9K
10.1M
Earning Date
04-29-2026
05-11-2026
Dividend Yield
2.43%
N/A
EPS Growth
16.06
N/A
EPS
3.83
N/A
Revenue
N/A
$76,201,000.00
Revenue This Year
$9.38
N/A
Revenue Next Year
$6.55
$27.22
P/E Ratio
$10.77
$22.58
Revenue Growth
N/A
N/A
52 Week Low
$27.58
$0.40
52 Week High
$44.85
$8.21

Technical Indicators

Market Signals
Indicator
FMBH
CTMX
Relative Strength Index (RSI) 54.29 48.64
Support Level $40.83 $3.55
Resistance Level $41.25 $6.20
Average True Range (ATR) 0.86 0.61
MACD 0.21 -0.02
Stochastic Oscillator 91.28 15.74

Price Performance

Historical Comparison
FMBH
CTMX

About FMBH First Mid Bancshares Inc.

First Mid Bancshares Inc is a United States based financial holding company. Through its wholly-owned subsidiary, First Mid Bank, it is engaged in the business of banking. The Company offers trust, farm services, investment services, and retirement planning through its wholly owned subsidiary, it also provides data processing services to affiliates and insurance products and services to customers through its subsidiary. The company's operations cover community banking, wealth management and insurance services. Key revenue is derived from the provision of community banking services.

About CTMX CytomX Therapeutics Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

Share on Social Networks: